Cabot Corporation (CBT) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 2026 (Fiscal Q2 2026). Cabot Corporation operates in two reportable segments: Reinforcement Materials (carbon black) and Performance Chemicals (specialty carbons, fumed metal oxides, battery materials, etc.). The company is a large accelerated filer incorporated in Delaware.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Net Sales | $904 million | $936 million | $1,753 million | $1,891 million |
| Gross Profit | $210 million | $241 million | $421 million | $476 million |
| Operating Income | $129 million | $162 million | $258 million | $317 million |
| Net Income (Cabot) | $68 million | $94 million | $141 million | $187 million |
| Diluted EPS | $1.27 | $1.69 | $2.64 | $3.36 |
| Operating Cash Flow (YTD) | $203 million (vs. $197 million YTD 2025) | |||
| Cash & Equivalents | $252 million (as of March 31, 2026) | |||
| Total Debt | $1,299 million ($175M short-term + $261M current LT + $863M LT) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3% in Q2 and 7% YTD compared to the prior year. The decline was driven by less favorable pricing and product mix in the Reinforcement Materials segment, attributed to lower raw material costs passed to customers and increased competitive intensity in Asia Pacific.
- Profitability Pressure: Operating income fell 20% in Q2 and 19% YTD. Gross profit per ton in Reinforcement Materials declined significantly due to pricing pressures.
- Segment Performance:
- Reinforcement Materials: Sales down $50M (Q2) and $141M (YTD). EBIT down $38M (Q2) and $66M (YTD).
- Performance Chemicals: Sales up $17M (Q2) and $6M (YTD). EBIT up $9M (Q2) and $12M (YTD), driven by favorable product mix and optimization.
- Acquisition Impact: The acquisition of Mexico Carbon Manufacturing (MXCB) for $68 million closed in Q2, contributing approximately $12 million in revenue for the quarter.
Guidance, Outlook, and Risks
- Restructuring Plans:
- 2026 PC Plan: Initiated in Q1 to cease fumed silica production in Barry, Wales. Total expected charges are $25 million ($13M recorded YTD). Additional $12M expected in FY2026/2027.
- Subsequent Event (May 1, 2026): Committed to a new restructuring plan to close the Campana, Argentina plant and units in Botlek, The Netherlands. Expected pre-tax charges of $79 million ($63M in FY2026, $16M in FY2027). Future cash outlays estimated at $24 million.
- Outlook: Management expects Reinforcement Materials EBIT to improve sequentially in Q3 due to product mix and full-quarter MXCB contribution. Performance Chemicals EBIT is expected to be relatively flat sequentially.
- Liquidity: The company maintains $1.1 billion in borrowing availability under credit agreements. Commercial paper outstanding was $148 million as of March 31, 2026.
- Risks: Significant exposure to respirator liabilities (reserve of $32 million), currency fluctuations, and raw material price volatility. The new restructuring plan carries risks regarding finalization of severance and asset retirement costs.
Investor Verification Checklist
- Restructuring Execution: Verify the timeline and cost accuracy of the new $79 million restructuring plan announced May 1, 2026, specifically regarding the Argentina and Netherlands closures.
- Pricing Power: Monitor the Reinforcement Materials segment for signs of stabilizing pricing and product mix in Asia Pacific amid competitive intensity.
- Debt Levels: Track the increase in short-term borrowings and commercial paper usage to fund the MXCB acquisition and working capital needs.
- Respirator Liabilities: Review updates on the $32 million reserve for respirator claims, noting the inherent uncertainty in future claim volumes and legal outcomes.
- Capital Allocation: Assess the impact of $101 million in share repurchases YTD alongside the new restructuring cash outlays.